Overall, our study identified a metabolic‐related gene, SLC16A3, which correlated with the tumour microenvironment, providing insights into the interplay between SLC16A3 and the immune landscape within HCC. This evidence concerns the gene SLC16A3 and hepatocellular carcinoma.